Table 3.

Patients who Remained HBsAg-positive vs those who Became HBsAg-negative

Characteristic	HBsAg-positive (n=27)	HBsAg negative (n=15)	p value
Age (years)*	47 (14–71)	48 (31–68)	0.48
Male Sex	22 (81%)	14 (93%)	0.39
Race: White or Caucasian	12	10
Black or African-American	2	1	0.38
Asian-American	13	4
ALT (U/L)*	96 (28–524)	167 (50–488)	0.19
APRI *	1.2 (0.2–12.9)	1.6 (0.3–6.2)	0.32
HBV DNA (log IU/mL)*	8.5 (5.5–10.1)	7.8 (5.3–10.4)	0.08
HBsAg concentration (log IU/mL)*	3.5 (2.0–5.3)	2.9 (1.9–4.4)	0.08
HBeAg positivity	17 (63%)	5 (33%)	0.11
Genotype: A	12	9
C	12	3	0.27
D	2	3
E	1	0
HAI score (0–18)*	10 (3–16)	12 (5–17)	0.51
Ishak score (0–6)*	4 (0–6)	4 (1–5)	0.64
Cirrhosis (Ishak 5 or 6)	9** (33%)	4 (27%)	0.73
Duration of follow up (years)*	14.3 (3.3–19.5)	16.3 (7.1–19.1)	0.59
Lamivudine resistance	18 (67%)	6 (40%)	0.09
Death or Transplant, liver-related	7 (26%)	0 (0%)	0.04

^*Median (range).

^**Includes one imputed case